Intra-Cellular Therapies (ITCI) Tops Q4 EPS by 13c

March 1, 2017 7:12 AM EST
Get Alerts ITCI Hot Sheet
Price: $43.18 +0.05%

EPS Growth %: +11.0%

Today's EPS Names:
More
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Intra-Cellular Therapies (NASDAQ: ITCI) reported Q4 EPS of ($0.64), $0.13 better than the analyst estimate of ($0.77). Revenue for the quarter came in at $97.9 thousand, versus $30.66 thousand reported last year.

For earnings history and earnings-related data on Intra-Cellular Therapies (ITCI) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

The Children's Investment Fund (TCI), Earnings